• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deals search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • People moves
    • Analysis
    • In Profile
    • Q&A
    • Videos
    • Comment
  •  
    Analysis
    • In Profile
    • Fundraising
    • Q&A
    • Comment
    • Videos
    • Podcast
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 
Unquote
  • Exits

SHS sells stake in Single Use Support

  • Harriet Matthews
  • Harriet Matthews
  • 14 January 2021
  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  

SHS has sold its stake in pharmaceutical logistics business Single Use Support (SUS) to US-based pharmaceutical business Pall.

The transaction generated a money multiple of more than 7x for SHS.

SHS acquired a minority stake of almost 20% in SUS in November 2019, investing via SHS V Fonds. The vehicle held a final close in July 2019 on €130m, and generally invests a maximum of €30m per company. SUS is the first exit from the vehicle.

Single Use Support

  • DEAL:

    Trade sale

  • LOCATION:

    Kufstein

  • SECTOR:

    Medical equipment

  • FOUNDED:

    2015

  • TURNOVER:

    >€10m

  • STAFF:

    >40

  • VENDOR:

    SHS

  • RETURNS:

    >7x

The exit opportunity arrived quicker than initially anticipated, SHS managing partner Sascha Alilovic told Unquote. "We expected to hold the company for much longer, maybe for three to five years – but the company was exploding in terms of revenues and customer growth, and the product became the gold standard in managing transportation for high-value liquids in the pharma space. So we thought it would be good to have a bigger partner to accompany that extreme growth."

The sale saw interest from both trade buyers and sponsors, Alilovic said. "We had interest from a number of companies supporting life science production and supply chain with innovative products, but also from high-growth cold chain logistics companies that focus on vaccine and gene therapies. We also had a significant number of financial sponsors looking at SUS to accompany them on their next step."

The GP said in a statement issued at the time of the investment that it intended to support the company's international expansion, as well as the development of its sales facilities. Asked about the company's growth during the investment period, Alilovic said: "We helped them with their legal and IP set up, looked at the supply chain and manufacturing capacity, and last but not least with the partnering process."

Company
SUS produces single-use bags for the transportation of liquids in the pharmaceuticals sector, as well as for frozen products. Founded in 2015 and based in Kufstein, the company now employs more than 40 people, compared with 15 employees in 2019.

People
SHS
– Uwe Steinbacher, Sascha Alilovic (managing partner).
Single Use Support
– Johannes Kirchmair, Thomas Wurm (founders, managing directors).

Advisers
Vendor
– Harris Williams (corporate finance); CMS (legal).

  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  
  • Topics
  • Exits
  • DACH
  • Healthcare
  • Trade sale
  • Germany

More on Exits

Public sector software
Partners Group to release IMs for Civica sale in mid-September

Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017

  • Exits
  • 04 September 2023
Lender taking the keys from a sponsor
Ares Management handed keys to two-thirds of UK sponsor’s portfolio

Lender provided GBP 500m for three of the GP's deals between 2016 and 2019, Debtwire reported

  • Financing
  • 30 August 2023
Luggage and airport services
Actera Group explores strategic options for Celebi Ground Handling

Several investors placed bids for the company in 2022 but mismatch in pricing didn't lead to a deal

  • Exits
  • 30 August 2023
HR software solutions providers
Main Capital’s Assessio to be sold to Pollen Street

Recruitment software company tripled in revenue under Main Capital’s ownership

  • Buyouts
  • 25 August 2023

Latest News

Fund closes in US dollars
  • Funds
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote

  • 05 September 2023
Clinical trials and biotechnology
  • Buyouts
Permira to take Ergomed private for GBP 703m

Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO

  • 04 September 2023
Public sector software
  • Exits
Partners Group to release IMs for Civica sale in mid-September

Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017

  • 04 September 2023
EMEA Public to Private M&A
  • Investments
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • 04 September 2023
Back to Top
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013